| 1 |
Liang L, Saunders C, Sanossian N. Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management. Food Science & Nutrition 2023. [DOI: 10.1002/fsn3.3229] [Reference Citation Analysis]
|
| 2 |
Romano KA, Nemet I, Prasad Saha P, Haghikia A, Li XS, Mohan ML, Lovano B, Castel L, Witkowski M, Buffa JA, Sun Y, Li L, Menge CM, Demuth I, König M, Steinhagen-Thiessen E, DiDonato JA, Deb A, Bäckhed F, Tang WHW, Naga Prasad SV, Landmesser U, Van Wagoner DR, Hazen SL. Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure. Circ Heart Fail 2023;16:e009972. [PMID: 36524472 DOI: 10.1161/CIRCHEARTFAILURE.122.009972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Rampanelli E, Nieuwdorp M. Gut microbiome in type 1 diabetes: the immunological perspective. Expert Rev Clin Immunol 2023;19:93-109. [PMID: 36401835 DOI: 10.1080/1744666X.2023.2150612] [Reference Citation Analysis]
|
| 4 |
Pereira MDL, Levy M, Nissapatorn V, de Oliveira GLV. Editorial: Women in microbiome in health and disease 2021. Front Cell Infect Microbiol 2022;12:1054190. [DOI: 10.3389/fcimb.2022.1054190] [Reference Citation Analysis]
|
| 5 |
Liu M, Nieuwdorp M, de Vos WM, Rampanelli E. Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders. Metabolites 2022;12:834. [PMID: 36144238 DOI: 10.3390/metabo12090834] [Reference Citation Analysis]
|
| 6 |
Li P, Liu F, Zhao M, Xu S, Li P, Cao J, Tian D, Tan Y, Zheng L, Cao X, Pan Y, Tang H, Wu Y, Sun Y. Prediction models constructed for Hashimoto’s thyroiditis risk based on clinical and laboratory factors. Front Endocrinol 2022;13:886953. [DOI: 10.3389/fendo.2022.886953] [Reference Citation Analysis]
|
| 7 |
Xu Y, Zhong F, Zheng X, Lai H, Wu C, Huang C. Disparity of Gut Microbiota Composition Among Elite Athletes and Young Adults With Different Physical Activity Independent of Dietary Status: A Matching Study. Front Nutr 2022;9:843076. [DOI: 10.3389/fnut.2022.843076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Giambò F, Costa C, Teodoro M, Fenga C. Role-Playing Between Environmental Pollutants and Human Gut Microbiota: A Complex Bidirectional Interaction. Front Med (Lausanne) 2022;9:810397. [PMID: 35252248 DOI: 10.3389/fmed.2022.810397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
de Oliveira GLV. Intestinal Dysbiosis in Autoimmune Diseases. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00038-3] [Reference Citation Analysis]
|
| 10 |
de Salis LVV, Martins LS, Rodrigues GSP, de Oliveira GLV. Dysbiosis and probiotic applications in autoimmune diseases. Translational Autoimmunity 2022. [DOI: 10.1016/b978-0-12-824390-9.00004-9] [Reference Citation Analysis]
|
| 11 |
Huang P, Hou Y, Zou Y, Ye X, Yu R, Yang S. The Causal Effects of Primary Biliary Cholangitis on Thyroid Dysfunction: A Two-Sample Mendelian Randomization Study. Front Genet 2021;12:791778. [PMID: 34956333 DOI: 10.3389/fgene.2021.791778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Gong B, Wang C, Meng F, Wang H, Song B, Yang Y, Shan Z. Association Between Gut Microbiota and Autoimmune Thyroid Disease: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:774362. [PMID: 34867823 DOI: 10.3389/fendo.2021.774362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Wu Y, Xu H, Tu X, Gao Z. The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension. Front Microbiol 2021;12:730809. [PMID: 34650536 DOI: 10.3389/fmicb.2021.730809] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 14 |
Lygina EA, Latyi VV. Life and Heritage of Hakaru Hashimoto. Clin Exp Thyroid 2021;17:20-23. [DOI: 10.14341/ket12562] [Reference Citation Analysis]
|
| 15 |
Shen W, Tang D, Deng Y, Li H, Wang T, Wan P, Liu R. Association of gut microbiomes with lung and esophageal cancer: a pilot study. World J Microbiol Biotechnol 2021;37:128. [PMID: 34212246 DOI: 10.1007/s11274-021-03086-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Priyadarshini M, Lednovich K, Xu K, Gough S, Wicksteed B, Layden BT. FFAR from the Gut Microbiome Crowd: SCFA Receptors in T1D Pathology. Metabolites 2021;11:302. [PMID: 34064625 DOI: 10.3390/metabo11050302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 17 |
Zou J, Reddivari L, Shi Z, Li S, Wang Y, Bretin A, Ngo VL, Flythe M, Pellizzon M, Chassaing B, Gewirtz AT. Inulin Fermentable Fiber Ameliorates Type I Diabetes via IL22 and Short-Chain Fatty Acids in Experimental Models. Cell Mol Gastroenterol Hepatol 2021;12:983-1000. [PMID: 33940221 DOI: 10.1016/j.jcmgh.2021.04.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 18 |
Marunaka Y. Roles of interstitial fluid pH and weak organic acids in development and amelioration of insulin resistance. Biochem Soc Trans 2021;49:715-26. [PMID: 33769491 DOI: 10.1042/BST20200667] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 19 |
Cho SW, Park YJ. Best Achievements in Translational and Basic Thyroidology in 2020. Endocrinol Metab (Seoul) 2021;36:36-40. [PMID: 33677924 DOI: 10.3803/EnM.2021.104] [Reference Citation Analysis]
|
| 20 |
Cayres LCF, de Salis LVV, Rodrigues GSP, Lengert AVH, Biondi APC, Sargentini LDB, Brisotti JL, Gomes E, de Oliveira GLV. Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis. Front Immunol 2021;12:579140. [PMID: 33746942 DOI: 10.3389/fimmu.2021.579140] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 21 |
Colucci R, Moretti S. Implication of Human Bacterial Gut Microbiota on Immune-Mediated and Autoimmune Dermatological Diseases and Their Comorbidities: A Narrative Review. Dermatol Ther (Heidelb) 2021;11:363-84. [PMID: 33507493 DOI: 10.1007/s13555-021-00485-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Amadei SS, Notario V. A Significant Question in Cancer Risk and Therapy: Are Antibiotics Positive or Negative Effectors? Current Answers and Possible Alternatives. Antibiotics (Basel) 2020;9:E580. [PMID: 32899961 DOI: 10.3390/antibiotics9090580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
